{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T01:24:33Z","timestamp":1790126673576,"version":"4.0.1"},"reference-count":147,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,4,5]],"date-time":"2026-04-05T00:00:00Z","timestamp":1775347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,5]],"date-time":"2026-04-05T00:00:00Z","timestamp":1775347200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1007\/s10067-026-08069-z","type":"journal-article","created":{"date-parts":[[2026,4,5]],"date-time":"2026-04-05T19:27:07Z","timestamp":1775417227000},"page":"3835-3851","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Regulatory T cells as a potential treatment for autoimmune inflammatory rheumatic and musculoskeletal diseases"],"prefix":"10.1007","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8602-0958","authenticated-orcid":false,"given":"Ian C.","family":"Chikanza","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clementine Sifiso Nomalizo","family":"Mnkandla-Khumalo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7670-3314","authenticated-orcid":false,"given":"Lazaros I.","family":"Sakkas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,5]]},"reference":[{"issue":"8","key":"8069_CR1","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1038\/nm.2425","volume":"17","author":"MA Linterman","year":"2011","unstructured":"Linterman MA, Pierson W, Lee SK, Kallies A, Kawamoto S, Rayner TF et al (2011) Foxp3+ follicular regulatory T cells control the germinal center response. Nat Med 17(8):975\u201382. https:\/\/doi.org\/10.1038\/nm.2425","journal-title":"Nat Med"},{"issue":"11","key":"8069_CR2","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1016\/j.it.2016.08.012","volume":"37","author":"M Kanamori","year":"2016","unstructured":"Kanamori M, Nakatsukasa H, Okada M, Lu Q, Yoshimura A (2016) Induced regulatory T cells: their development, stability, and applications. Trends Immunol 37(11):803\u2013811","journal-title":"Trends Immunol"},{"key":"8069_CR3","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1126\/science.1060133","volume":"106","author":"RS Wildin","year":"2002","unstructured":"Wildin RS et al (2002) Clinical and molecular features of the immunodysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) syndrome. Science 106:131\u2013135. https:\/\/doi.org\/10.1126\/science.1060133","journal-title":"Science"},{"issue":"10","key":"8069_CR4","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-022-04563-0","volume":"79","author":"S Yan","year":"2022","unstructured":"Yan S, Kotschenreuther K, Deng S, Kofler DM (2022) Regulatory T cells in rheumatoid arthritis: functions, development, regulation, and therapeutic potential. Cell Mol Life Sci 79(10):533. https:\/\/doi.org\/10.1007\/s00018-022-04563-0","journal-title":"Cell Mol Life Sci"},{"issue":"5","key":"8069_CR5","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1016\/j.immuni.2007.09.010","volume":"27","author":"JA Hill","year":"2007","unstructured":"Hill JA, Feuerer M, Tash K, Haxhinasto S, Perez J, Melamed R, Mathis D, Benoist C (2007) Foxp3 transcription-factor-dependent and -independent regulation of the regulatory T cell transcriptional signature. Immunity 27(5):786\u2013800. https:\/\/doi.org\/10.1016\/j.immuni.2007.09.010","journal-title":"Immunity"},{"issue":"11","key":"8069_CR6","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.it.2013.08.003","volume":"34","author":"CY Luo","year":"2013","unstructured":"Luo CY, Li MO (2013) Transcriptional control of regulatory T cell development and function. Trends Immunol 34(11):531\u2013539. https:\/\/doi.org\/10.1016\/j.it.2013.08.003","journal-title":"Trends Immunol"},{"issue":"7","key":"8069_CR7","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1038\/nri2343","volume":"8","author":"DA Vignali","year":"2008","unstructured":"Vignali DA, Collison LW, Workman CJ (2008) How regulatory T cells work. Nat Rev Immunol 8(7):523\u2013532. https:\/\/doi.org\/10.1038\/nri2343","journal-title":"Nat Rev Immunol"},{"issue":"5","key":"8069_CR8","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1016\/j.cell.2008.05.009","volume":"133","author":"S Sakaguchi","year":"2008","unstructured":"Sakaguchi S, Yamaguchi T, Nomura T, Ono M (2008) Regulatory T cells and immune tolerance. Cell 133(5):775\u2013787. https:\/\/doi.org\/10.1016\/j.cell.2008.05.009","journal-title":"Cell"},{"issue":"2","key":"8069_CR9","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1016\/j.jaci.2006.10.007","volume":"119","author":"AA Caudy","year":"2007","unstructured":"Caudy AA, Reddy ST, Chatila T, Atkinson JP, Verbsky JW (2007) CD25 deficiency causes an immune dysregulation, polyendocrinopathy, enteropathy, X-linked\u2013like syndrome, and defective IL-10 expression from CD4 lymphocytes. J Allergy Clin Immunol 119(2):482\u2013487","journal-title":"J Allergy Clin Immunol"},{"key":"8069_CR10","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1154575","author":"NT Cheru","year":"2023","unstructured":"Cheru NT, Hafler DA, Sumida T (2023) Regulatory T cells in peripheral tissue tolerance and diseases. Frontiers in Immunology. https:\/\/doi.org\/10.3389\/fimmu.2023.1154575","journal-title":"Frontiers in Immunology"},{"issue":"10","key":"8069_CR11","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1038\/nri3155","volume":"12","author":"CS Hsieh","year":"2012","unstructured":"Hsieh CS, Lee HM, Lio CW (2012) Selection of regulatory T cells in the thymus. Nat Rev Immunol 12(10):157\u201367. https:\/\/doi.org\/10.1038\/nri3155","journal-title":"Nat Rev Immunol"},{"issue":"30","key":"8069_CR12","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1016\/j.cell.2008.05.009","volume":"133","author":"S Sakaguchi","year":"2008","unstructured":"Sakaguchi S, Yamaguchi T, Nomura T, Ono M (2008) Regulatory T cells and immune tolerance. Cell 133(30):775\u201387. https:\/\/doi.org\/10.1016\/j.cell.2008.05.009","journal-title":"Cell"},{"issue":"12","key":"8069_CR13","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1038\/ni.1952","volume":"11","author":"LW Collison","year":"2010","unstructured":"Collison LW, Chaturvedi V, Henderson AL, Giacomin PR, Guy C, Bankoti J, Finkelstein D, Forbes K, Workman CJ, Brown SA, Rehg JE, Jones ML, Ni HT, Artis D, Turk MJ, Vignali DA (2010) IL-35-mediated induction of a potent regulatory T cell population. Nat Immunol 11(12):1093\u2013101. https:\/\/doi.org\/10.1038\/ni.1952","journal-title":"Nat Immunol"},{"issue":"6","key":"8069_CR14","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1111\/j.1756-185X.2012.01813.x","volume":"15","author":"IS Yoo","year":"2012","unstructured":"Yoo IS, Lee JH, Song ST, Kim JH, Lee HJ, Kang SW (2012) T-helper 17 cells: the driving force of psoriasis and psoriatic arthritis. Int J Rheum Dis 15(6):531\u2013537","journal-title":"Int J Rheum Dis"},{"key":"8069_CR15","doi-asserted-by":"publisher","first-page":"2886","DOI":"10.1002\/eji.200526106","volume":"35","author":"MC Kullberg","year":"2005","unstructured":"Kullberg MC, Hay V, Cheever AW, Mamura M, Sher A, Letterio JJ, Shevach EM, Piccirillo CA (2005) TGF-\u03b21 production by CD4+CD25+ regulatory T cells is not essential for suppression of intestinal inflammation. Eur J Immunol 35:2886\u20132895. https:\/\/doi.org\/10.1002\/eji.200526106","journal-title":"Eur J Immunol"},{"key":"8069_CR16","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1084\/jem.20051166","volume":"202","author":"J Kearley","year":"2005","unstructured":"Kearley J, Barker JE, Robinson DS, Lloyd CM (2005) Resolution of airway inflammation and hyperreactivity after in vivo transfer of CD4+CD25+ regulatory T cells is interleukin 10 dependent. J Exp Med 202:1539\u20131547","journal-title":"J Exp Med"},{"issue":"4","key":"8069_CR17","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1016\/j.immuni.2008.02.017","volume":"28","author":"YP Rubtsov","year":"2008","unstructured":"Rubtsov YP, Rasmussen JP, Chi EY, Fontenot J, Castelli L, Ye X, Treuting P, Siewe L, Roers A, Henderson WR Jr, Muller W, Rudensky AY (2008) Regulatory T cell-derived interleukin-10 limits inflammation at environmental interfaces. Immunity 28(4):546\u201358. https:\/\/doi.org\/10.1016\/j.immuni.2008.02.017","journal-title":"Immunity"},{"key":"8069_CR18","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.750542","volume":"12","author":"P Grover","year":"2021","unstructured":"Grover P, Goel PN, Greene MI (2021) Regulatory T cells: regulation of identity and function. Front Immunol 12:750542. https:\/\/doi.org\/10.3389\/fimmu.2021.750542","journal-title":"Front Immunol"},{"key":"8069_CR19","doi-asserted-by":"publisher","unstructured":"Turner JA, Stephen-Victor E, Wang S, Rivas MN, Abdel-Gadir A, Harb H et al (2020) Regulatory T cell-derived TGF-Beta1 controls multiple checkpoints governing allergy and autoimmunity. Immunity 53(6):1202\u201314 e6. https:\/\/doi.org\/10.1016\/j.immuni.2020.10.002","DOI":"10.1016\/j.immuni.2020.10.002"},{"key":"8069_CR20","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1038\/s41423-023-01036-7","volume":"20","author":"J Wang","year":"2023","unstructured":"Wang J, Zhao X, Wan YY (2023) Intricacies of TGF-\u03b2 signaling in Treg and Th17 cell biology. Cell Mol Immunol 20:1002\u20131022. https:\/\/doi.org\/10.1038\/s41423-023-01036-7","journal-title":"Cell Mol Immunol"},{"issue":"1","key":"8069_CR21","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.immuni.2008.05.007","volume":"29","author":"XO Yang","year":"2008","unstructured":"Yang XO, Nurieva R, Martinez GJ, Kang HS, Chung Y, Pappu BP, Shah B, Chang SH, Schluns KS, Watowich SS, Feng XH, Jetten AM, Dong C (2008) Molecular antagonism and plasticity of regulatory and inflammatory T cell programs. Immunity 29(1):44\u201356. https:\/\/doi.org\/10.1016\/j.immuni.2008.05.007","journal-title":"Immunity"},{"issue":"7169","key":"8069_CR22","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1038\/nature06306","volume":"450","author":"LW Collison","year":"2007","unstructured":"Collison LW, Workman CJ, Kuo TT et al (2007) The inhibitory cytokine IL-35 contributes to regulatory T-cell function. Nature 450(7169):566\u20139. https:\/\/doi.org\/10.1038\/nature06306","journal-title":"Nature"},{"issue":"6","key":"8069_CR23","doi-asserted-by":"publisher","first-page":"3578","DOI":"10.4049\/jimmunol.179.6.3578","volume":"179","author":"N Oberle","year":"2007","unstructured":"Oberle N, Eberhardt N, Falk CS, Krammer PH, Suri-Payer E (2007) Rapid suppression of cytokine transcription in human CD4+CD25 T cells by CD4+Foxp3+ regulatory t cells: independence of IL-2 consumption, TGF-beta, and various inhibitors of TCR signaling. J Immunol 179(6):3578\u20133587. https:\/\/doi.org\/10.4049\/jimmunol.179.6.3578","journal-title":"J Immunol"},{"issue":"12","key":"8069_CR24","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1038\/ni1536","volume":"8","author":"P Pandiyan","year":"2007","unstructured":"Pandiyan P, Zheng L, Ishihara S, Reed J, Lenardo MJ (2007) CD4+CD25+Foxp3+regulatory T cells induce cytokine deprivation-mediated apoptosis of effector CD4+ T cells. Nat Immunol 8(12):1353\u20131362. https:\/\/doi.org\/10.1038\/ni1536","journal-title":"Nat Immunol"},{"issue":"5899","key":"8069_CR25","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1126\/science.1160062","volume":"322","author":"K Wing","year":"2008","unstructured":"Wing K, Onishi Y, Prieto-Martin P, Yamaguchi T, Miyara M, Fehervari Z, Nomura T, Sakaguchi S (2008) CTLA-4 control over Foxp3+regulatory T cell function. Science 322(5899):271\u2013275. https:\/\/doi.org\/10.1126\/science.1160062","journal-title":"Science"},{"issue":"7","key":"8069_CR26","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/0167-5699(96)30017-0","volume":"17","author":"D Kaplan","year":"1996","unstructured":"Kaplan D (1996) Autocrine secretion and the physiological concentration of cytokines. Immunol Today 17(7):303\u2013304. https:\/\/doi.org\/10.1016\/0167-5699(96)30017-0","journal-title":"Immunol Today"},{"issue":"9","key":"8069_CR27","doi-asserted-by":"publisher","first-page":"5916","DOI":"10.4049\/jimmunol.180.9.5916","volume":"180","author":"B Liang","year":"2008","unstructured":"Liang B, Workman C, Lee J, Chew C, Dale BM, Colonna L et al (2008) Regulatory T cells inhibit dendritic cells by lymphocyte activation gene-3 engagement of MHC class II. J Immunol 180(9):5916\u201326. https:\/\/doi.org\/10.4049\/jimmunol.180.9.5916","journal-title":"J Immunol"},{"key":"8069_CR28","doi-asserted-by":"publisher","first-page":"3925","DOI":"10.1182\/blood-2005-11-4502","volume":"107","author":"DM Zhao","year":"2006","unstructured":"Zhao DM, Thornton AM, DiPaolo RJ, Shevach EM (2006) Activated CD4+CD25+ T cells selectively kill B lymphocytes. Blood 107:3925\u20133932","journal-title":"Blood"},{"issue":"4","key":"8069_CR29","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/j.immuni.2007.08.014","volume":"27","author":"X Cao","year":"2007","unstructured":"Cao X, Cai SF, Fehniger TA, Song J, Collins LI, Piwnica-Worms DR, Ley TJ (2007) Granzyme B and perforin are important for regulatory T cell-mediated suppression of tumor clearance. Immunity 27(4):635\u2013646. https:\/\/doi.org\/10.1016\/j.immuni.2007.08.014","journal-title":"Immunity"},{"issue":"1","key":"8069_CR30","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1146\/annurev.immunol.14.1.233","volume":"14","author":"DJ Lenschow","year":"1996","unstructured":"Lenschow DJ, Walunas TL, Bluestone JA (1996) CD28\/B7 system of T cell costimulation. Annu Rev Immunol 14(1):233\u2013258. https:\/\/doi.org\/10.1146\/annurev.immunol.14.1.233","journal-title":"Annu Rev Immunol"},{"issue":"2","key":"8069_CR31","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/s1074-7613(02)00362-x","volume":"17","author":"AV Collins","year":"2002","unstructured":"Collins AV, Brodie DW, Gilbert RJ, Iaboni A, Manso-Sancho R, Walse B, Stuart DI, van der Merwe PA, Davis SJ (2002) The interaction properties of costimulatory molecules revisited. Immunity 17(2):201\u201310. https:\/\/doi.org\/10.1016\/s1074-7613(02)00362-x","journal-title":"Immunity"},{"issue":"2","key":"8069_CR32","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1084\/jem.184.2.783","volume":"184","author":"NJ Karandikar","year":"1996","unstructured":"Karandikar NJ, Vanderlugt CL, Walunas TL, Miller SD, Bluestone JA (1996) CTLA-4: a negative regulator of autoimmune disease. J Exp Med 184(2):783\u2013788. https:\/\/doi.org\/10.1084\/jem.184.2.783","journal-title":"J Exp Med"},{"issue":"6939","key":"8069_CR33","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1038\/nature01621","volume":"423","author":"H Ueda","year":"2003","unstructured":"Ueda H, Howson JM, Esposito L, Heward J, Snook H, Chamberlain G, Rainbow DB, Hunter KM, Smith AN, Di Genova G, Herr MH, Dahlman I, Payne F, Smyth D, Lowe C, Twells RC, Howlett S, Healy B, Nutland S, Rance HE, Everett V, Smink LJ, Lam AC, Cordell HJ, Walker NM, Bordin C, Hulme J, Motzo C, Cucca F, Hess JF, Metzker ML, Rogers J, Gregory S, Allahabadia A, Nithiyananthan R, Tuomilehto-Wolf E, Tuomilehto J, Bingley P, Gillespie KM, Undlien DE, R\u00f8nningen KS, Guja C, Ionescu-T\u00eergovi\u015fte C, Savage DA, Maxwell AP, Carson DJ, Patterson CC, Franklyn JA, Clayton DG, Peterson LB, Wicker LS, Todd JA, Gough SC (2003) Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature 423(6939):506\u2013511. https:\/\/doi.org\/10.1038\/nature01621","journal-title":"Nature"},{"issue":"7","key":"8069_CR34","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1007\/s10875-019-00684-7","volume":"39","author":"P Georgiev","year":"2019","unstructured":"Georgiev P, Charbonnier LM, Chatila TA (2019) Regulatory T cells: the many faces of Foxp3. J Clin Immunol 39(7):623\u2013640. https:\/\/doi.org\/10.1007\/s10875-019-00684-7. (Epub 2019 Sep 2. PMID: 31478130; PMCID: PMC6754763)","journal-title":"J Clin Immunol"},{"issue":"3","key":"8069_CR35","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1038\/nm.3085","volume":"19","author":"H Nie","year":"2013","unstructured":"Nie H, Zheng Y, Li R, Guo TB, He D, Fang L et al (2013) Phosphorylation of FOXP3 controls regulatory T cell function and is inhibited by TNF-\u03b1 in rheumatoid arthritis. Nat Med 19(3):322\u20138. https:\/\/doi.org\/10.1038\/nm.3085","journal-title":"Nat Med"},{"key":"8069_CR36","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.947636","volume":"13","author":"K Kotschenreuther","year":"2022","unstructured":"Kotschenreuther K, Yan S, Kofler DM (2022) Migration and homeostasis of regulatory T cells in rheumatoid arthritis. Front Immunol 13:947636. https:\/\/doi.org\/10.3389\/fimmu.2022.947636","journal-title":"Front Immunol"},{"issue":"6258","key":"8069_CR37","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1126\/science.aad0616","volume":"350","author":"HJ Kim","year":"2015","unstructured":"Kim HJ, Barnitz RA, Kreslavsky T, Brown FD, Moffett H, Lemieux ME, Kaygusuz Y, Meissner T, Holderried TA, Chan S, Kastner P, Haining WN, Cantor H (2015) Stable inhibitory activity of regulatory T cells requires the transcription factor Helios. Science 350(6258):334\u2013339. https:\/\/doi.org\/10.1126\/science.aad0616","journal-title":"Science"},{"issue":"6","key":"8069_CR38","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1080\/08820139.2018.1480029","volume":"47","author":"P Zafari","year":"2018","unstructured":"Zafari P, Yari K, Mostafaei S, Iranshahi N, Assar S, Fekri A, Taghadosi M (2018) Analysis of Helios gene expression and Foxp3 TSDR methylation in the newly diagnosed rheumatoid arthritis patients. Immunol Invest 47(6):632\u2013642. https:\/\/doi.org\/10.1080\/08820139.2018.1480029","journal-title":"Immunol Invest"},{"issue":"5944","key":"8069_CR39","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1126\/science.1176077","volume":"325","author":"F Pan","year":"2009","unstructured":"Pan F, Yu H, Dang EV, Barbi J, Pan X, Grosso JF, Jinasena D, Sharma SM, McCadden EM, Getnet D, Drake CG, Liu JO, Ostrowski MC, Pardoll DM (2009) Eos mediates Foxp3-dependent gene silencing in CD4+ regulatory T cells. Science 325(5944):1142\u20131146. https:\/\/doi.org\/10.1126\/science.1176077","journal-title":"Science"},{"issue":"1","key":"8069_CR40","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s10528-015-9702-0","volume":"54","author":"X Cai","year":"2016","unstructured":"Cai X, Liu X, Du S, Xu X, Liu A, Ge X, Qiao Y, Jiang Y (2016) Overexpression of Aiolos in peripheral blood mononuclear cell subsets from patients with systemic lupus erythematosus and rheumatoid arthritis. Biochem Genet 54(1):73\u201382. https:\/\/doi.org\/10.1007\/s10528-015-9702-0","journal-title":"Biochem Genet"},{"issue":"6","key":"8069_CR41","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1136\/ard.2009.111211","volume":"69","author":"M Biniecka","year":"2010","unstructured":"Biniecka M, Kennedy A, Fearon U, Ng CT, Veale DJ, O\u2019Sullivan JN (2010) Oxidative damage in synovial tissue is associated with in vivo hypoxic status in the arthritic joint. Ann Rheum Dis 69(6):1172\u20131178. https:\/\/doi.org\/10.1136\/ard.2009.111211","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"8069_CR42","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1182\/blood-2005-11-4567","volume":"108","author":"X Valencia","year":"2006","unstructured":"Valencia X, Stephens G, Goldbach-Mansky R, Wilson M, Shevach EM, Lipsky PE (2006) TNF downmodulates the function of human CD4+CD25hi T-regulatory cells. Blood 108(1):253\u2013261. https:\/\/doi.org\/10.1182\/blood-2005-11-4567","journal-title":"Blood"},{"issue":"12","key":"8069_CR43","doi-asserted-by":"publisher","first-page":"3774","DOI":"10.1002\/art.22277","volume":"54","author":"E Baecklund","year":"2006","unstructured":"Baecklund E, Backlin C, Iliadou A, Granath F, Ekbom A, Amini RM, Feltelius N, Enblad G, Sundstr\u00f6m C, Klareskog L, Askling J, Rosenquist R (2006) Characteristics of diffuse large B cell lymphomas in rheumatoid arthritis. Arthritis Rheum 54(12):3774\u20133781. https:\/\/doi.org\/10.1002\/art.22277","journal-title":"Arthritis Rheum"},{"issue":"7","key":"8069_CR44","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1093\/intimm\/dxn044","volume":"20","author":"M Bonelli","year":"2008","unstructured":"Bonelli M, Savitskaya A, von dalwigk K, Steiner CW, Aletaha D, Smolen JS, Scheinecker C (2008) Quantitative and qualitative deficiencies of regulatory T cells in patients with systemic lupus erythematosus (SLE). Int Immunol 20(7):861\u20138. https:\/\/doi.org\/10.1093\/intimm\/dxn044","journal-title":"Int Immunol"},{"key":"8069_CR45","doi-asserted-by":"publisher","first-page":"391","DOI":"10.3389\/fimmu.2019.00391","volume":"10","author":"L \u00c1lvarez-Rodr\u00edguez","year":"2019","unstructured":"\u00c1lvarez-Rodr\u00edguez L, Mart\u00ednez-Taboada V, Calvo-Al\u00e9n J, Beares I, Villa L-H (2019) Altered Th17\/Treg ratio in peripheral blood of systemic lupus erythematosus but not primary antiphospholipid syndrome. Front Immunol 10:391","journal-title":"Front Immunol"},{"issue":"12","key":"8069_CR46","first-page":"6247","volume":"184","author":"M Bonelli","year":"2010","unstructured":"Bonelli M, G\u00f6schl L, Bl\u00fcml S et al (2010) CD4\u207aCD25\u207aFoxp3\u207a T cells: a stable regulatory T cell subset in systemic lupus erythematosus? J Immunol 184(12):6247\u20136256","journal-title":"J Immunol"},{"issue":"11","key":"8069_CR47","first-page":"803","volume":"11","author":"K Koga","year":"2012","unstructured":"Koga K, Oka M, Takemura Y et al (2012) Cytokine-induced functional defects in Tregs from patients with SLE. Autoimmun Rev 11(11):803\u2013810","journal-title":"Autoimmun Rev"},{"issue":"2","key":"8069_CR48","first-page":"209","volume":"131","author":"J Yang","year":"2009","unstructured":"Yang J, Chu Y, Yang X et al (2009) Th17 and Treg imbalance in systemic lupus erythematosus. Clin Immunol 131(2):209\u2013217","journal-title":"Clin Immunol"},{"issue":"12","key":"8069_CR49","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1038\/ncprheum0346","volume":"2","author":"LI Sakkas","year":"2006","unstructured":"Sakkas LI, Chikanza IC, Platsoucas CD (2006) Mechanisms of disease: the role of immune cells in the pathogenesis of systemic sclerosis. Nat Clin Pract Rheumatol 2(12):679\u2013685. https:\/\/doi.org\/10.1038\/ncprheum0346","journal-title":"Nat Clin Pract Rheumatol"},{"issue":"5","key":"8069_CR50","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1111\/j.1365-2133.2010.09633.x","volume":"162","author":"E Antiga","year":"2010","unstructured":"Antiga E, Quaglino P, Bellandi S, Volpi W, Del Bianco E, Comessatti A et al (2010) Regulatory T cells in the skin lesions and blood of patients with systemic sclerosis and morphoea. Br J Dermatol 162(5):1056\u20131063. https:\/\/doi.org\/10.1111\/j.1365-2133.2010.09633.x","journal-title":"Br J Dermatol"},{"issue":"3","key":"8069_CR51","doi-asserted-by":"publisher","first-page":"205","DOI":"10.3109\/03009742.2010.528021","volume":"40","author":"G Papp","year":"2011","unstructured":"Papp G, Horvath IF, Barath S, Gyimesi E, Sipka S, Szodoray P, Zeher M (2011) Altered T-cell and regulatory cell repertoire in patients with diffuse cutaneous systemic sclerosis. Scand J Rheumatol 40(3):205\u2013210. https:\/\/doi.org\/10.3109\/03009742.2010.528021","journal-title":"Scand J Rheumatol"},{"key":"8069_CR52","doi-asserted-by":"publisher","unstructured":"Wang YY, Wang Q, Sun XH, Liu RZ, Shu Y, Kanekura T et al (2014) DNA hypermethylation of the forkhead box protein 3 (FOXP3) promoter in CD4+ T cells of patients with systemic sclerosis. Br J Dermatol 171(1):39\u201347. https:\/\/doi.org\/10.1111\/bjd.12913","DOI":"10.1111\/bjd.12913"},{"key":"8069_CR53","doi-asserted-by":"publisher","unstructured":"MacDonald KG, Dawson NAJ, Huang Q, Dunne JV, Levings MK, Broaddy R (2015) Regulatory T cells produce profibrotic cytokines in the skin of patients with systemic sclerosis. J Allergy Clin Immunol 135(4):946-955.e9. https:\/\/doi.org\/10.1016\/j.jaci.2014.12.1932","DOI":"10.1016\/j.jaci.2014.12.1932"},{"key":"8069_CR54","doi-asserted-by":"publisher","unstructured":"Ugor E, Simon D, Almanzar G, Pap R, Najbauer J, N\u00e9meth, P, Balogh P, Prelog M, Czirj\u00e1k L, Berki (2017) Increased proportions of functionally impaired regulatory T cell subsets in systemic sclerosis. Clin Immunol 184:54\u201362. https:\/\/doi.org\/10.1016\/j.clim.2017.05.013","DOI":"10.1016\/j.clim.2017.05.013"},{"key":"8069_CR55","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.02356","volume":"9","author":"C Frantz","year":"2018","unstructured":"Frantz C, Auffray C, Avouac J, Allanore Y (2018) Regulatory T cells in systemic sclerosis. Front Immunol 9:2356. https:\/\/doi.org\/10.3389\/fimmu.2018.02356","journal-title":"Front Immunol"},{"issue":"3","key":"8069_CR56","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20190103","volume":"217","author":"N Frangogiannis","year":"2020","unstructured":"Frangogiannis N (2020) Transforming growth factor-\u03b2 in tissue fibrosis. J Exp Med 217(3):e20190103. https:\/\/doi.org\/10.1084\/jem.20190103","journal-title":"J Exp Med"},{"issue":"1","key":"8069_CR57","doi-asserted-by":"publisher","first-page":"3","DOI":"10.7555\/JBR.31.20170034","volume":"32","author":"NB Ayers","year":"2018","unstructured":"Ayers NB, Sun CM, Chen SY (2018) Transforming growth factor-\u03b2 signaling in systemic sclerosis. J Biomed Res 32(1):3","journal-title":"J Biomed Res"},{"issue":"5","key":"8069_CR58","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1093\/rheumatology\/keq414","volume":"50","author":"H Tsukamoto","year":"2011","unstructured":"Tsukamoto H, Nagafuji K, Horiuchi T, Mitoma H, Niiro H, Arinobu Y, Inoue Y, To K, Miyamoto T, Iwasaki H et al (2011) Analysis of immune reconstitution after autologous CD34 + stem\/progenitor cell transplantation for systemic sclerosis: predominant reconstitution of Th1 CD4 + T cells. Rheumatology 50(5):944\u201352. https:\/\/doi.org\/10.1093\/rheumatology\/keq414","journal-title":"Rheumatology"},{"key":"8069_CR59","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1007\/s00296-010-1728-3","volume":"32","author":"A Stelmaszczyk-Emmel","year":"2012","unstructured":"Stelmaszczyk-Emmel A, Jackowska T, Rutkowska-Sak L, Marusak-Banacka M, W\u0105sik M (2012) Identification, frequency, activation and function of CD4+ CD25 high FoxP3+ regulatory T cells in children with juvenile idiopathic arthritis. Rheumatol Int 32:1147\u20131154","journal-title":"Rheumatol Int"},{"issue":"12","key":"8069_CR60","doi-asserted-by":"publisher","first-page":"5616","DOI":"10.4049\/jimmunol.1500391","volume":"195","author":"D Bending","year":"2015","unstructured":"Bending D, Giannakopoulou E, Lom H, Wedderburn LR (2015) Synovial regulatory T cells occupy a discrete TCR niche in human arthritis and require local signals to stabilize FOXP3 protein expression. J Immunol 195(12):5616\u20135624","journal-title":"J Immunol"},{"issue":"1","key":"8069_CR61","doi-asserted-by":"publisher","DOI":"10.1186\/s12969-024-01006-x","volume":"22","author":"N Quilis","year":"2024","unstructured":"Quilis N, Mesa-Del-Castillo Bermejo P, Boix P, Juanola O, Bernabeu P, Franc\u00e9s R, Andr\u00e9s M (2024) Peripheral blood regulatory T cells and disease activity, quality of life, and outcomes in children with juvenile idiopathic arthritis. Pediatr Rheumatol Online J 22(1):69. https:\/\/doi.org\/10.1186\/s12969-024-01006-x","journal-title":"Pediatr Rheumatol Online J"},{"issue":"2","key":"8069_CR62","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1302\/2046-3758.122.BJR-2022-0195.R1","volume":"12","author":"H Liao","year":"2023","unstructured":"Liao H, Tsai C (2023) Cytokines and regulatory T cells in ankylosing spondylitis. Bone Joint Res 12(2):133\u2013137. https:\/\/doi.org\/10.1302\/2046-3758.122.BJR-2022-0195.R1","journal-title":"Bone Joint Res"},{"issue":"1","key":"8069_CR63","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-24924-w","volume":"12","author":"JN Pouw","year":"2022","unstructured":"Pouw JN, Olde Nordkamp MA, van Kempen T, Concepcion AN, van Laar JM, van Wijk F, Spierings J, Leijten EF, Boes M (2022) Regulatory T cells in psoriatic arthritis: an IL-17A-producing, Foxp3intCD161+ ROR\u03b3t+ ICOS+ phenotype, that associates with the presence of ADAMTSL5 autoantibodies. Sci Rep 12(1):20675","journal-title":"Sci Rep"},{"key":"8069_CR64","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1286251","volume":"14","author":"T Fukasawa","year":"2023","unstructured":"Fukasawa T, Yamashita T, Enomoto A, Norimatsu Y, Toyama S, Yoshizaki-Ogawa A, Tateishi S, Kanda H, Miyagawa K, Sato S, Yoshizaki A (2023) The optimal use of tildrakizumab in the elderly via improvement of Treg function and its preventive effect of psoriatic arthritis. Front Immunol 14:1286251. https:\/\/doi.org\/10.3389\/fimmu.2023.1286251","journal-title":"Front Immunol"},{"issue":"7","key":"8069_CR65","doi-asserted-by":"publisher","DOI":"10.3390\/jcm6070065","volume":"6","author":"K Matsui","year":"2017","unstructured":"Matsui K, Sano HT (2017) Helper 17 cells in primary Sj\u00f6gren\u2019s syndrome. J Clin Med 6(7):65. https:\/\/doi.org\/10.3390\/jcm6070065","journal-title":"J Clin Med"},{"key":"8069_CR66","doi-asserted-by":"publisher","first-page":"3088","DOI":"10.1093\/rheumatology\/kez004","volume":"60","author":"GM Verstappen","year":"2019","unstructured":"Verstappen GM, Kroese FGM, Bootsma H (2019) T cells in primary Sj\u00f6gren\u2019s syndrome: targets for early intervention. Rheumatology (Oxford) 60:3088\u20133098","journal-title":"Rheumatology (Oxford)"},{"key":"8069_CR67","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.02933","volume":"10","author":"AA Starshinova","year":"2020","unstructured":"Starshinova AA, Malkova AM, Basantsova NY, Zinchenko YS, Kudryavtsev IV, Ershov GA, Soprun LA, Mayevskaya VA, Churilov LP, Yablonskiy PK (2020) Sarcoidosis as an autoimmune disease. Front Immunol 10:2933. https:\/\/doi.org\/10.3389\/fimmu.2019.02933","journal-title":"Front Immunol"},{"issue":"5","key":"8069_CR68","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/S2213-2600(18)30064-X","volume":"6","author":"P Spagnolo","year":"2018","unstructured":"Spagnolo P, Rossi G, Trisolini R, Sverzellati N, Baughman RP, Wells AU (2018) Pulmonary sarcoidosis. Lancet Respir Med 6(5):389\u2013402. https:\/\/doi.org\/10.1016\/S2213-2600(18)30064-X","journal-title":"Lancet Respir Med"},{"issue":"8","key":"8069_CR69","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics13081378","volume":"13","author":"I Kudryavtsev","year":"2023","unstructured":"Kudryavtsev I, Zinchenko Y, Starshinova A, Serebriakova M, Malkova A, Akisheva T, Kudlay D, Glushkova A, Yablonskiy P, Shoenfeld Y (2023) Circulating regulatory T cell subsets in patients with sarcoidosis. Diagnostics (Basel) 13(8):1378. https:\/\/doi.org\/10.3390\/diagnostics13081378","journal-title":"Diagnostics (Basel)"},{"key":"8069_CR70","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2023.103120","volume":"149","author":"JR Miedema","year":"2024","unstructured":"Miedema JR, de Jong LJ, van Uden D, Bergen IM, Mirjam K, Broos CE, Kahlmann V, Wijsenbeek MS, Hendriks RW, Corneth OB (2024) Circulating T cells in sarcoidosis have an aberrantly activated phenotype that correlates with disease outcome. J Autoimmun 149:103120. https:\/\/doi.org\/10.1016\/j.jaut.2023.103120","journal-title":"J Autoimmun"},{"issue":"8","key":"8069_CR71","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1056\/NEJM198108203050804","volume":"305","author":"GW Hunninghake","year":"1981","unstructured":"Hunninghake GW, Crystal RG (1981) Pulmonary sarcoidosis: a disorder mediated by excess helper T-lymphocyte activity at sites of disease activity. N Engl J Med 305(8):429\u2013434. https:\/\/doi.org\/10.1056\/NEJM198108203050804","journal-title":"N Engl J Med"},{"issue":"2","key":"8069_CR72","doi-asserted-by":"publisher","first-page":"497","DOI":"10.2353\/ajpath.2009.080580","volume":"174","author":"C Taflin","year":"2009","unstructured":"Taflin C et al (2009) Foxp3+ regulatory T cells suppress early stages of granuloma formation but have little impact on sarcoidosis lesions. Am J Pathol 174(2):497\u2013508. https:\/\/doi.org\/10.2353\/ajpath.2009.080580","journal-title":"Am J Pathol"},{"key":"8069_CR73","unstructured":"Patterson KC, Miller WT, Hancock WW, Akimova T (2023) Front Immunol. https:\/\/converis.ub.bw\/converis\/portal\/detail\/Publication\/9595267?auxfun=&lang=en_GB"},{"issue":"11","key":"8069_CR74","doi-asserted-by":"publisher","first-page":"21463","DOI":"10.3390\/ijms141121463","volume":"14","author":"H Huang","year":"2013","unstructured":"Huang H, Lu Z, Jiang C, Liu J, Wang Y, Xu Z (2013) Imbalance between Th17 and regulatory T-cells in sarcoidosis. Int J Mol Sci 14(11):21463\u201321473. https:\/\/doi.org\/10.3390\/ijms141121463","journal-title":"Int J Mol Sci"},{"issue":"2","key":"8069_CR75","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1002\/art.1780370206","volume":"37","author":"JC Jennette","year":"1994","unstructured":"Jennette JC, Falk RJ, Andrassy K, Bacon PA, Churg J, Gross WL, Hagen EC, Hoffman GS, Hunder GG, Kallenberg CG (1994) Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum 37(2):187\u201392. https:\/\/doi.org\/10.1002\/art.1780370206","journal-title":"Arthritis Rheum"},{"key":"8069_CR76","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.844300","volume":"13","author":"K Jin","year":"2022","unstructured":"Jin K, Parreau S, Warrington KJ, Koster MJ, Berry GJ, Goronzy JJ, Weyand CM (2022) Regulatory T cells in autoimmune vasculitis. Front Immunol 13:844300. https:\/\/doi.org\/10.3389\/fimmu.2022.844300","journal-title":"Front Immunol"},{"issue":"1","key":"8069_CR77","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1097\/BOR.0000000000000915","volume":"35","author":"A Mirouse","year":"2023","unstructured":"Mirouse A, Cacoub P, Saadoun D (2023) Regulatory t cells and systemic vasculitis. Curr Opin Rheumatol 35(1):25\u201330. https:\/\/doi.org\/10.1097\/BOR.0000000000000915","journal-title":"Curr Opin Rheumatol"},{"key":"8069_CR78","doi-asserted-by":"publisher","first-page":"i11","DOI":"10.1093\/rheumatology\/keae518","volume":"64","author":"ME Free","year":"2025","unstructured":"Free ME (2025) Emerging cell therapies in the vasculitis field. Rheumatology 64:i11\u2013i14. https:\/\/doi.org\/10.1093\/rheumatology\/keae518","journal-title":"Rheumatology"},{"issue":"7","key":"8069_CR79","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a018341","volume":"5","author":"OJ Harrison","year":"2013","unstructured":"Harrison OJ, Powrie FM (2013) Regulatory t cells and immune tolerance in the intestine. Cold Spring Harb Perspect Biol 5(7):a018341. https:\/\/doi.org\/10.1101\/cshperspect.a018341","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"8069_CR80","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00680","volume":"10","author":"EB Okeke","year":"2019","unstructured":"Okeke EB, Uzonna JE (2019) The pivotal role of regulatory, T cells in the regulation of innate immune cells. Front Immunol 10:680. https:\/\/doi.org\/10.3389\/fimmu.2019.00680","journal-title":"Front Immunol"},{"issue":"1","key":"8069_CR81","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1146\/annurev-immunol-030409-101225","volume":"28","author":"A Kaser","year":"2010","unstructured":"Kaser A, Zeissig S, Blumberg RS (2010) Inflammatory bowel disease. Annu Rev Immunol 28(1):573\u2013621. https:\/\/doi.org\/10.1146\/annurev-immunol-030409-101225","journal-title":"Annu Rev Immunol"},{"issue":"1","key":"8069_CR82","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1146\/annurev.immunol.021908.132657","volume":"27","author":"A Izcue","year":"2009","unstructured":"Izcue A, Coombes JL, Powrie F (2009) Regulatory lymphocytes and intestinal inflammation. Annu Rev Immunol 27(1):313\u2013338. https:\/\/doi.org\/10.1146\/annurev.immunol.021908.132657","journal-title":"Annu Rev Immunol"},{"issue":"1","key":"8069_CR83","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1146\/annurev.immunol.24.021605.090547","volume":"24","author":"SF Ziegler","year":"2006","unstructured":"Ziegler SF (2006) FOXP3: of mice and men. Annu Rev Immunol 24(1):209\u2013226. https:\/\/doi.org\/10.1146\/annurev.immunol.24.021605.090547","journal-title":"Annu Rev Immunol"},{"issue":"4","key":"8069_CR84","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1097\/00002281-200307000-00010","volume":"15","author":"E Gambineri","year":"2003","unstructured":"Gambineri E, Torgerson TR, Ochs HD (2003) Immune dysregulation, polyendocrinopathy, enteropathy, and X-linked inheritance (IPEX), a syndrome of systemic autoimmunity caused by mutations of FOXP3, a critical regulator of T-cell homeostasis. Curr Opin Rheumatol 15(4):430\u2013435. https:\/\/doi.org\/10.1097\/00002281-200307000-00010","journal-title":"Curr Opin Rheumatol"},{"issue":"6","key":"8069_CR85","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1016\/j.immuni.2014.05.013","volume":"40","author":"C Huttenhower","year":"2014","unstructured":"Huttenhower C, Kostic AD, Xavier RJ (2014) Inflammatory bowel disease as a model for translating the microbiome. Immunity 40(6):843\u2013854. https:\/\/doi.org\/10.1016\/j.immuni.2014.05.013","journal-title":"Immunity"},{"key":"8069_CR86","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2012-13-9-r79","volume":"13","author":"XC Morgan","year":"2012","unstructured":"Morgan XC, Tickle TL, Sokol H, Gevers D, Devaney KL, Ward DV, Reyes JA, Shah SA, LeLeiko N, Snapper SB, Bousvaros A, Korzenik J, Sands BE, Xavier RJ, Huttenhower C (2012) Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment. Genome Biol 13:R79. https:\/\/doi.org\/10.1186\/gb-2012-13-9-r79","journal-title":"Genome Biol"},{"key":"8069_CR87","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1053\/j.gastro.2015.08.006","volume":"149","author":"M Dubinsky","year":"2015","unstructured":"Dubinsky M, Braun J (2015) Diagnostic and prognostic microbial biomarkers in inflammatory bowel diseases. Gastroenterology 149:1265-1274.e3. https:\/\/doi.org\/10.1053\/j.gastro.2015.08.006","journal-title":"Gastroenterology"},{"key":"8069_CR88","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1004573","volume":"11","author":"S Nayfach","year":"2015","unstructured":"Nayfach S, Bradley PH, Wyman SK, Laurent TJ, Williams A, Eisen JA, Pollard KS, Sharpton TJ (2015) Automated and accurate estimation of gene family abundance from shotgun metagenomes. PLoS Comput Biol 11:e1004573. https:\/\/doi.org\/10.1371\/journal.pcbi.1004573","journal-title":"PLoS Comput Biol"},{"key":"8069_CR89","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1126\/science.1198469","volume":"331","author":"K Atarashi","year":"2011","unstructured":"Atarashi K, Tanoue T, Shima T, Imaoka A, Kuwahara T, Momose Y, Cheng G, Yamasaki S, Saito T, Ohba Y, Taniguchi T, Takeda K, Hori S, Ivanov II, Umesaki Y, Itoh K, Honda K (2011) Induction of colonic regulatory T cells by indigenous Clostridium species. Science 331:337\u2013341. https:\/\/doi.org\/10.1126\/science.1198469","journal-title":"Science"},{"key":"8069_CR90","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1146\/annurev-immunol-020711-074937","volume":"30","author":"K Honda","year":"2012","unstructured":"Honda K, Littman DR (2012) The microbiome in infectious disease and inflammation. Annu Rev Immunol 30:759\u2013795. https:\/\/doi.org\/10.1146\/annurev-immunol-020711-074937","journal-title":"Annu Rev Immunol"},{"issue":"1","key":"8069_CR91","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.smim.2015.02.002","volume":"27","author":"J Huehn","year":"2015","unstructured":"Huehn J, Beyer M (2015) Epigenetic and transcriptional control of Foxp3+ regulatory T cells. Semin Immunol 27(1):10\u201318. https:\/\/doi.org\/10.1016\/j.smim.2015.02.002","journal-title":"Semin Immunol"},{"issue":"1","key":"8069_CR92","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1002\/eji.201444577","volume":"45","author":"Y Kitagawa","year":"2015","unstructured":"Kitagawa Y, Ohkura N, Sakaguchi S (2015) Epigenetic control of thymic Treg-cell development. Eur J Immunol 45(1):11\u201316. https:\/\/doi.org\/10.1002\/eji.201444577","journal-title":"Eur J Immunol"},{"key":"8069_CR93","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1444533","volume":"15","author":"Y Yue","year":"2024","unstructured":"Yue Y, Ren Y, Lu C, Li P, Zhang G (2024) Epigenetic regulation of human FOXP3+ Tregs: from homeostasis maintenance to pathogen defense. Front Immunol 15:1444533. https:\/\/doi.org\/10.3389\/fimmu.2024.1444533","journal-title":"Front Immunol"},{"issue":"10","key":"8069_CR94","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1111\/j.1742-4658.2011.08089.x","volume":"278","author":"F Sato","year":"2011","unstructured":"Sato F, Tsuchiya S, Meltzer SJ, Shimizu K (2011) MicroRNAs and epigenetics. FEBS J 278(10):1598\u20131609. https:\/\/doi.org\/10.1111\/j.1742-4658.2011.08089.x","journal-title":"FEBS J"},{"issue":"3","key":"8069_CR95","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.tips.2010.12.004","volume":"32","author":"N Ohkura","year":"2011","unstructured":"Ohkura N, Hamaguchi M, Sakaguchi S (2011) FOXP3+ regulatory T cells: control of FOXP3 expression by pharmacological agents. Trends Pharmacol Sci 32(3):158\u2013166. https:\/\/doi.org\/10.1016\/j.tips.2010.12.004","journal-title":"Trends Pharmacol Sci"},{"issue":"2","key":"8069_CR96","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.0050038","volume":"5","author":"S Floess","year":"2007","unstructured":"Floess S, Freyer J, Siewert C, Baron U, Olek S, Polansky J, Schlawe K, Chang HD, Bopp T, Schmitt E, Klein-Hessling S, Serfling E, Hamann A, Huehn J (2007) Epigenetic control of the foxp3 locus in regulatory T cells. PLoS Biol 5(2):e38. https:\/\/doi.org\/10.1371\/journal.pbio.0050038","journal-title":"PLoS Biol"},{"key":"8069_CR97","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1016\/j.jhep.2012.05.022","volume":"57","author":"MS Longhi","year":"2012","unstructured":"Longhi MS, Ma Y, Mieli-Vergani G, Vergani D (2012) Regulatory T cells in autoimmune hepatitis. J Hepatol 57:932\u2013933. https:\/\/doi.org\/10.1016\/j.jhep.2012.05.022","journal-title":"J Hepatol"},{"issue":"12","key":"8069_CR98","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1016\/j.autrev.2011.05.004","volume":"10","author":"M Miyara","year":"2011","unstructured":"Miyara M, Gorochov G, Ehrenstein M, Musset L, Sakaguchi S, Amoura Z (2011) Human FoxP3+ regulatory T cells in systemic autoimmune diseases. Autoimmun Rev 10(12):744\u2013755. https:\/\/doi.org\/10.1016\/j.autrev.2011.05.004","journal-title":"Autoimmun Rev"},{"issue":"2","key":"8069_CR99","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1186\/ar1500","volume":"7","author":"H Kelchtermans","year":"2005","unstructured":"Kelchtermans H, De Klerck B, Mitera T, Van Balen M, Bullens D, Billiau A, Leclercq G, Matthys P (2005) <article-title update=\"added\">Defective CD4+CD25+regulatory T cell functioning in collagen-induced arthritis: an important factor in pathogenesis, counter-regulated by endogenous IFN-\u03b3. Arthritis Res Ther 7(2):402\u201315. https:\/\/doi.org\/10.1186\/ar1500","journal-title":"Arthritis Res Ther"},{"issue":"3","key":"8069_CR100","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1002\/art.22414","volume":"56","author":"JM van Amelsfort","year":"2007","unstructured":"van Amelsfort JM, van Roon JA, Noordegraaf M, Jacobs KM, Bijlsma JW, Lafeber FP, Taams LS (2007) Proinflammatory mediator-induced reversal of CD4+,CD25+ regulatory T cell-mediated suppression in rheumatoid arthritis. Arthritis Rheum 56(3):732\u201342. https:\/\/doi.org\/10.1002\/art.22414","journal-title":"Arthritis Rheum"},{"issue":"1","key":"8069_CR101","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.clim.2014.03.016","volume":"153","author":"N Marek-Trzonkowska","year":"2014","unstructured":"Marek-Trzonkowska N, My\u015bliwiec M, Dobyszuk A, Grabowska M, Derkowska I, Ju\u015bci\u0144ska J et al (2014) Therapy of type 1 diabetes with CD4+CD25highCD127-regulatory T cells prolongs survival of pancreatic islets - results of one year follow-up. Clin Immunol 153(1):23\u201330. https:\/\/doi.org\/10.1016\/j.clim.2014.03.016","journal-title":"Clin Immunol"},{"issue":"1","key":"8069_CR102","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2022.2035117","volume":"18","author":"TK Goswami","year":"2022","unstructured":"Goswami TK, Singh M, Dhawan M, Mitra S, Emran TB, Rabaan AA et al (2022) Regulatory T cells (Tregs) and their therapeutic potential against autoimmune disorders - advances and challenges. Hum Vaccin Immunother 18(1):2035117. https:\/\/doi.org\/10.1080\/21645515.2022.2035117","journal-title":"Hum Vaccin Immunother"},{"issue":"12","key":"8069_CR103","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1136\/ard-2022-222501","volume":"81","author":"JY Humrich","year":"2022","unstructured":"Humrich JY, Cacoub P, Rosenzwajg M, Pitoiset F, Pham HP, Guidoux J, Leroux D, Vazquez T, Riemekasten G, Smolen JS, Tsokos G, Klatzmann D (2022) Low-dose interleukin-2 therapy in active systemic lupus erythematosus (LUPIL)-2): a multicentre, double-blind,randomised and placebo-controlled phase II trial. Ann Rheum Dis 81(12):1685\u20131694. https:\/\/doi.org\/10.1136\/ard-2022-222501","journal-title":"Ann Rheum Dis"},{"issue":"12","key":"8069_CR104","doi-asserted-by":"publisher","first-page":"5451","DOI":"10.4049\/jimmunol.1490019","volume":"192","author":"SA Rosenberg","year":"2014","unstructured":"Rosenberg SA (2014) IL-2: the first effective immunotherapy for human cancer. J Immunol 192(12):5451\u20135458. https:\/\/doi.org\/10.4049\/jimmunol.1490019","journal-title":"J Immunol"},{"issue":"6","key":"8069_CR105","doi-asserted-by":"publisher","first-page":"2409","DOI":"10.1182\/blood-2005-06-2399","volume":"107","author":"M Ahmadzadeh","year":"2006","unstructured":"Ahmadzadeh M, Rosenberg SA (2006) IL-2 administration increases CD4+ CD25hi Foxp3+ regulatory T cells in cancer patients. Blood 107(6):2409\u20132414","journal-title":"Blood"},{"issue":"5","key":"8069_CR106","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1038\/s41435-023-00221-y","volume":"24","author":"V Lykhopiy","year":"2023","unstructured":"Lykhopiy V, Malviya V, Humblet-Baron S, Schlenner SM (2023) IL-2 immunotherapy for targeting regulatory T cells in autoimmunity. Genes Immun 24(5):248\u2013262. https:\/\/doi.org\/10.1038\/s41435-023-00221-y","journal-title":"Genes Immun"},{"key":"8069_CR107","doi-asserted-by":"publisher","unstructured":"Dixit N, Fanton C, Langowski JL, Kirksey Y, Kirk P, Chang T, et al (2021). NKTR-358: A novel regulatory T-cell stimulator that selectively stimulates expansion and suppressive function of regulatory T cells for the treatment of autoimmune diseases. J Transl Autoimmun 4:100103.https:\/\/doi.org\/10.1016\/j.jtauto.2021.100103","DOI":"10.1016\/j.jtauto.2021.100103"},{"issue":"9","key":"8069_CR108","doi-asserted-by":"publisher","first-page":"2579","DOI":"10.4049\/jimmunol.1800907","volume":"201","author":"NC Ward","year":"2018","unstructured":"Ward NC, Yu A, Moro A, Ban Y, Chen X, Hsiung S et al (2018) IL-2\/CD25: a long-acting fusion protein that promotes immune tolerance by selectively targeting the IL-2 receptor on regulatory T cells. J Immunol 201(9):2579\u20132592","journal-title":"J Immunol"},{"issue":"5","key":"8069_CR109","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1016\/j.immuni.2015.04.015","volume":"42","author":"JB Spangler","year":"2015","unstructured":"Spangler JB, Tomala J, Luca VC, Jude KM, Dong S, Ring AM et al (2015) Antibodies to interleukin-2 elicit selective T cell subset potentiation through distinct conformational mechanisms. Immunity 42(5):815-825.6","journal-title":"Immunity"},{"issue":"10429","key":"8069_CR110","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1016\/S0140-6736(23)02650-8","volume":"403","author":"J Rech","year":"2024","unstructured":"Rech J, Tascilar K, Hagen M, Kleyer A, Manger B, Schoenau V et al (2024) Abatacept inhibits inflammation and onset of rheumatoid arthritis in individuals at high risk (ARIAA): a randomised, international, multicentre, double-blind, placebo-controlled trial. Lancet 403(10429):850\u2013859. https:\/\/doi.org\/10.1016\/S0140-6736(23)02650-8","journal-title":"Lancet"},{"issue":"4","key":"8069_CR111","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1080\/1744666X.2019.1579642","volume":"15","author":"M Pombo-Suarez","year":"2019","unstructured":"Pombo-Suarez M, Gomez-Reino JJ (2019) Abatacept for the treatment of rheumatoid arthritis. Expert Rev Clin Immunol 15(4):319\u2013326. https:\/\/doi.org\/10.1080\/1744666X.2019.1579642","journal-title":"Expert Rev Clin Immunol"},{"issue":"6","key":"8069_CR112","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1007\/s40272-020-00422-2","volume":"22","author":"HI Brunner","year":"2020","unstructured":"Brunner HI, Wong R, Nys M, Kou TD, Dominique A, Martini A et al (2020) Abatacept: a review of the treatment of polyarticular-course juvenile idiopathic arthritis. Paediatr Drugs 22(6):653\u2013672. https:\/\/doi.org\/10.1007\/s40272-020-00422-2","journal-title":"Paediatr Drugs"},{"issue":"17","key":"8069_CR113","doi-asserted-by":"publisher","first-page":"1865","DOI":"10.1200\/JCO.20.01086","volume":"39","author":"B Watkins","year":"2021","unstructured":"Watkins B, Qayed M, McCracken C, Bratrude B, Betz K, Suessmuth Y et al (2021) Phase II trial of costimulation blockade with abatacept for prevention of acute GVHD. J Clin Oncol 39(17):1865\u20131877. https:\/\/doi.org\/10.1200\/JCO.20.01086","journal-title":"J Clin Oncol"},{"issue":"3","key":"8069_CR114","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.immuni.2006.03.001","volume":"24","author":"JA Bluestone","year":"2006","unstructured":"Bluestone JA, Clair EWS, Turka LA (2006) CTLA4Ig: bridging the basic immunology with clinical application. Immunity 24(3):233\u2013238","journal-title":"Immunity"},{"key":"8069_CR115","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1411393","volume":"15","author":"M Rossi","year":"2024","unstructured":"Rossi M, Breman E (2024) Engineering strategies to safely drive CAR T-cells into the future. Front Immunol 15:1411393. https:\/\/doi.org\/10.3389\/fimmu.2024.1411393","journal-title":"Front Immunol"},{"key":"8069_CR116","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.00554","volume":"9","author":"M Biswas","year":"2018","unstructured":"Biswas M, Kumar SRP, Terhorst C, Herzog RW (2018) Gene therapy with regulatory T cells: a beneficial alliance. Front Immunol 9:554. https:\/\/doi.org\/10.3389\/fimmu.2018.00554","journal-title":"Front Immunol"},{"issue":"7","key":"8069_CR117","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1182\/blood-2014-04-566786","volume":"125","author":"YC Kim","year":"2015","unstructured":"Kim YC, Zhang AH, Su Y, Rieder SA, Rossi RJ, Ettinger RA, Pratt KP, Shevach EM, Scott DW (2015) Engineered antigen-specific human regulatory T cells: immunosuppression of FVIII-specific T-and B-cell responses. Blood 125(7):1107\u20131115","journal-title":"Blood"},{"issue":"11","key":"8069_CR118","doi-asserted-by":"publisher","first-page":"3619","DOI":"10.1172\/JCI33185","volume":"118","author":"JYS Tsang","year":"2008","unstructured":"Tsang JYS, Tanriver Y, Jiang S, Xue SA, Ratnasothy K, Chen D et al (2008) Conferring indirect allospecificity on CD4+ CD25+ Tregs by TCR gene transfer favors transplantation tolerance in mice. J Clin Invest 118(11):3619\u20133628. https:\/\/doi.org\/10.1172\/JCI33185","journal-title":"J Clin Invest"},{"issue":"1","key":"8069_CR119","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-04392-5","volume":"9","author":"NM Chapman","year":"2018","unstructured":"Chapman NM, Zeng H, Nguyen TLM, Wang Y, Vogel P, Dhungana Y et al (2018) mTOR coordinates transcriptional programs and mitochondrial metabolism of activated Treg\u00a0subsets to protect tissue homeostasis. Nat Commun 9(1):2095. https:\/\/doi.org\/10.1038\/s41467-018-04392-5","journal-title":"Nat Commun"},{"issue":"12","key":"8069_CR120","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1038\/ni.3577","volume":"17","author":"VA Gerriets","year":"2016","unstructured":"Gerriets VA, Kishton RJ, Johnson MO, Cohen S, Siska PJ, Nichols AG et al (2016) Foxp3 and Toll-like receptor signaling balance Treg cell anabolic metabolism for suppression. Nat Immunol 17(12):1459\u20131466. https:\/\/doi.org\/10.1038\/ni.3577","journal-title":"Nat Immunol"},{"issue":"1","key":"8069_CR121","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.cmet.2018.09.020","volume":"29","author":"L Li","year":"2019","unstructured":"Li L, Liu X, Sanders KL, Edwards JL, Ye J, Si F, Gao A, Huang L, Hsueh EC, Ford DA, Hoft DF, Peng G (2019) TLR8-mediated metabolic control of human treg function: a mechanistic target for cancer immunotherapy. Cell Metab 29(1):103-123.e5. https:\/\/doi.org\/10.1016\/j.cmet.2018.09.020","journal-title":"Cell Metab"},{"issue":"5609","key":"8069_CR122","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1126\/science.1079490","volume":"299","author":"S Hori","year":"2003","unstructured":"Hori S, Nomura T, Sakaguchi S (2003) Control of regulatory T cell development by the transcription factor Foxp3. Science 299(5609):1057\u20131061","journal-title":"Science"},{"key":"8069_CR123","doi-asserted-by":"crossref","unstructured":"Fontenot JD, Gavin MA, Rudensky AY (2017) Pillars article: Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat Immunol 4:330\u2013336.\u00a0J Immunol 198(3):986-992","DOI":"10.1093\/jimmunol\/198.3.986"},{"issue":"6","key":"8069_CR124","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1038\/nri3464","volume":"13","author":"S Sakaguchi","year":"2013","unstructured":"Sakaguchi S, Vignali DA, Rudensky AY, Niec RE, Waldmann H (2013) The plasticity and stability of regulatory T cells. Nat Rev Immunol 13(6):461\u2013467. https:\/\/doi.org\/10.1038\/nri3464","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"8069_CR125","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1007\/s12016-018-8721-0","volume":"58","author":"R Qiu","year":"2020","unstructured":"Qiu R, Zhou L, Ma Y, Zhou L, Liang T, Shi L, Long J, Yuan D (2020) Regulatory T cell plasticity and stability and autoimmune diseases. Clin Rev Allergy Immunol 58(1):52\u201370. https:\/\/doi.org\/10.1007\/s12016-018-8721-0","journal-title":"Clin Rev Allergy Immunol"},{"issue":"3","key":"8069_CR126","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1038\/nri.2015.18","volume":"16","author":"M DuPage","year":"2016","unstructured":"DuPage M, Bluestone JA (2016) Harnessing the plasticity of CD4(+) T cells to treat immune-mediated disease. Nat Rev Immunol 16(3):149\u2013163. https:\/\/doi.org\/10.1038\/nri.2015.18","journal-title":"Nat Rev Immunol"},{"issue":"6","key":"8069_CR127","doi-asserted-by":"publisher","first-page":"1903","DOI":"10.1073\/pnas.0811556106","volume":"106","author":"N Komatsu","year":"2009","unstructured":"Komatsu N, Mariotti-Ferrandiz ME, Wang Y, Malissen B, Waldmann H, Hori S (2009) Heterogeneity of natural Foxp3+ T cells: a committed regulatory T-cell lineage and an uncommitted minor population retaining plasticity. Proc Natl Acad Sci U S A 106(6):1903\u20131908. https:\/\/doi.org\/10.1073\/pnas.0811556106","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"8069_CR128","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1038\/nm.3432","volume":"20","author":"N Komatsu","year":"2014","unstructured":"Komatsu N, Okamoto K, Sawa S, Nakashima T, Oh-hora M, Kodama T, Tanaka S, Bluestone JA, Takayanagi H (2014) Pathogenic conversion of Foxp3+ T cells into TH17 cells in autoimmune arthritis. Nat Med 20(1):62\u201368. https:\/\/doi.org\/10.1038\/nm.3432","journal-title":"Nat Med"},{"issue":"11","key":"8069_CR129","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1016\/j.it.2016.08.012","volume":"37","author":"M Kanamori","year":"2016","unstructured":"Kanamori M, Nakatsukasa H, Okada M, Lu Q, Yoshimura A (2016) Induced regulatory T cells: their development, stability, and applications. Trends Immunol 37(11):803\u2013811. https:\/\/doi.org\/10.1016\/j.it.2016.08.012","journal-title":"Trends Immunol"},{"issue":"1","key":"8069_CR130","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cll.2018.11.001","volume":"39","author":"H Allos","year":"2019","unstructured":"Allos H, Al Dulaijan BS, Choi J, Azzi J (2019) Regulatory T cells for more targeted immunosuppressive therapies. Clin Lab Med 39(1):1\u201313. https:\/\/doi.org\/10.1016\/j.cll.2018.11.001","journal-title":"Clin Lab Med"},{"key":"8069_CR131","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1038\/ni1488","volume":"8","author":"L Zhou","year":"2007","unstructured":"Zhou L, Ivanov II, Spolski R, Min R et al (2007) IL-6 programs TH-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways. Nat Immunol 8:967\u2013974","journal-title":"Nat Immunol"},{"issue":"6","key":"8069_CR132","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.2337\/dbi18-0058","volume":"70","author":"M Bettini","year":"2021","unstructured":"Bettini M, Bettini ML (2021) Function, failure and the future potential of Tregs in type 1 diabetes. Diabetes 70(6):1211\u20131219. https:\/\/doi.org\/10.2337\/dbi18-0058","journal-title":"Diabetes"},{"key":"8069_CR133","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.616949","volume":"11","author":"L Rocamora-Reverte","year":"2021","unstructured":"Rocamora-Reverte L, Melzer FL, W\u00fcrzner R, Weinberger B (2021) The complex role of regulatory T cells in immunity and aging. Front Immunol 11:616949. https:\/\/doi.org\/10.3389\/fimmu.2020.616949","journal-title":"Front Immunol"},{"key":"8069_CR134","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2022.102888","volume":"132","author":"J McGovern","year":"2022","unstructured":"McGovern J, Holler A, Thomas S, Stauss HJ (2022) Forced Fox-P3 expression can improve the safety and antigen-specific function of engineered regulatory T cells. J Autoimmun 132:102888. https:\/\/doi.org\/10.1016\/j.jaut.2022.102888","journal-title":"J Autoimmun"},{"issue":"1","key":"8069_CR135","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.ymthe.2017.10.012","volume":"26","author":"KT Marcucci","year":"2018","unstructured":"Marcucci KT, Jadlowsky JK, Hwang WT, Suhoski-Davis M, Gonzalez VE, Kulikovskaya I et al (2018) Retroviral and lentiviral safety analysis of gene-modified T cell products and infused HIV and oncology patients. Mol Ther 26(1):269\u2013279. https:\/\/doi.org\/10.1016\/j.ymthe.2017.10.012","journal-title":"Mol Ther"},{"issue":"132","key":"8069_CR136","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3003761","volume":"4","author":"J Scholler","year":"2012","unstructured":"Scholler J, Brady TL, Binder-Scholl G, Hwang WT, Plesa G, Hege KM et al (2012) Decade-long safety and function of retroviral-modified chimeric antigen receptor T cells. Sci Transl Med 4(132):132ra53. https:\/\/doi.org\/10.1126\/scitranslmed.3003761","journal-title":"Sci Transl Med"},{"issue":"1","key":"8069_CR137","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-021-00487-6","volume":"6","author":"JT Bulcha","year":"2021","unstructured":"Bulcha JT, Wang Y, Ma H, Tai PWL, Gao G (2021) Viral vector platforms within the gene therapy landscape. Signal Transduct Target Ther 6(1):53. https:\/\/doi.org\/10.1038\/s41392-021-00487-6","journal-title":"Signal Transduct Target Ther"},{"issue":"3","key":"8069_CR138","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1056\/NEJM200301163480314","volume":"348","author":"S Hacein-Bey-Abina","year":"2003","unstructured":"Hacein-Bey-Abina S, von Kalle C, Schmidt M, Le Deist F, Wulffraat N, McIntyre E et al (2003) A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency. N Engl J Med 348(3):255\u20136. https:\/\/doi.org\/10.1056\/NEJM200301163480314","journal-title":"N Engl J Med"},{"issue":"1-2","key":"8069_CR139","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.ymgme.2003.08.016","volume":"80","author":"SE Raper","year":"2003","unstructured":"Raper SE, Chirmule N, Lee FS, Wivel NA, Bagg A, Gao GP, Wilson JM, Batshaw ML (2003) Fatal systemic inflammatory response syndrome in an ornithine transcarbamylase deficient patient following adenoviral gene transfer. Mol Genet Metab 80(1\u20132):148\u201358. https:\/\/doi.org\/10.1016\/j.ymgme.2003.08.016","journal-title":"Mol Genet Metab"},{"issue":"8","key":"8069_CR140","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1182\/blood-2014-01-545020","volume":"124","author":"B Philip","year":"2014","unstructured":"Philip B, Kokalaki E, Mekkaoui L, Thomas S, Straathof K, Flutter B et al (2014) A highly compact epitope-based marker\/suicide gene for easier and safer T-cell therapy. Blood 124(8):1277\u201387. https:\/\/doi.org\/10.1182\/blood-2014-01-545020","journal-title":"Blood"},{"issue":"5","key":"8069_CR141","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1182\/blood-2011-02-337360","volume":"118","author":"X Wang","year":"2011","unstructured":"Wang X, Chang WC, Wong CW, Colcher D, Sherman M, Ostberg JR, Forman SJ, Riddell SR, Jensen MC (2011) A transgene-encoded cell surface polypeptide for selection, in vivo tracking, and ablation of engineered cells. Blood 118(5):1255\u20131263. https:\/\/doi.org\/10.1182\/blood-2011-02-337360","journal-title":"Blood"},{"issue":"7","key":"8069_CR142","doi-asserted-by":"publisher","DOI":"10.3390\/cells9071608","volume":"9","author":"M Naeem","year":"2014","unstructured":"Naeem M, Majeed S, Hoque MZ, Ahmad I (2014) Latest developed strategies to minimize the off-target effects in CRISPR-Cas-mediated genome editing. Cells 9(7):1608. https:\/\/doi.org\/10.3390\/cells9071608","journal-title":"Cells"},{"issue":"1","key":"8069_CR143","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1101\/gr.162339.113","volume":"24","author":"SW Cho","year":"2009","unstructured":"Cho SW, Kim S, Kim Y, Kweon J, Kim HS, Bae S, Kim JS (2009) Analysis of off-target effects of CRISPR\/Cas-derived RNA-guided endonucleases and nickases. Genome Res 24(1):132\u2013141. https:\/\/doi.org\/10.1101\/gr.162339.113","journal-title":"Genome Res"},{"issue":"2","key":"8069_CR144","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0004643","volume":"4","author":"T Gogishvili","year":"2009","unstructured":"Gogishvili T, Langenhorst D, L\u00fchder F, Elias F, Elflein K, Dennehy KM, Gold R, H\u00fcnig T (2009) Rapid regulatory T-cell response prevents cytokine storm in CD28 superagonist treated mice. PLoS One 4(2):e4643. https:\/\/doi.org\/10.1371\/journal.pone.0004643","journal-title":"PLoS One"},{"issue":"5","key":"8069_CR145","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1002\/ijc.25132","volume":"127","author":"IE Galani","year":"2010","unstructured":"Galani IE, Wendel M, Stojanovic A, Jesiak M, M\u00fcller MM, Schellack C, Suri-Payer E, Cerwenka A (2010) Regulatory T cells control macrophage accumulation and activation in lymphoma. Int J Cancer 127(5):1131\u20131140. https:\/\/doi.org\/10.1002\/ijc.25132","journal-title":"Int J Cancer"},{"issue":"3","key":"8069_CR146","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1111\/pedi.12597","volume":"19","author":"MJ Redondo","year":"2018","unstructured":"Redondo MJ, Steck AK, Pugliese A (2018) Genetics of type 1 diabetes. Pediatr Diabetes 19(3):346\u2013353","journal-title":"Pediatr Diabetes"},{"issue":"8","key":"8069_CR147","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1007\/s10067-015-2902-5","volume":"34","author":"LI Sakkas","year":"2015","unstructured":"Sakkas LI, Simopoulou T, Katsiari C, Bogdanos D, Chikanza IC (2015) Early systemic sclerosis-opportunities for treatment. Clin Rheumatol 34(8):1327\u201331. https:\/\/doi.org\/10.1007\/s10067-015-2902-5","journal-title":"Clin Rheumatol"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-026-08069-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-026-08069-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-026-08069-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T04:26:49Z","timestamp":1783398409000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-026-08069-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,5]]},"references-count":147,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["8069"],"URL":"https:\/\/doi.org\/10.1007\/s10067-026-08069-z","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,5]]},"assertion":[{"value":"12 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 April 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}